Juan L. Rivera-Correa (@drjriveracorrea) 's Twitter Profile
Juan L. Rivera-Correa

@drjriveracorrea

👨🏽‍🏫👨🏽‍🔬Immunologist passionate about Malaria and tropical infections🦠 Producto UPR🇵🇷 views are my own. Also on @drjriveracorrea.bsky.social

ID: 128698733

linkhttps://sites.google.com/view/rivera-correalab/ calendar_today01-04-2010 23:07:24

672 Tweet

165 Takipçi

274 Takip Edilen

Dr. Arnaldo Díaz (@adiaz_phd) 's Twitter Profile Photo

📢 Applications are now open! We are now accepting applications for the Amgen Scholars Program at UTSW Graduate School of Biomedical Sciences. Dive into cutting-edge research, attend skill-building sessions, and connect with our vibrant scientific community Amgen Scholars Global Program Office Apply here ➡️ bit.ly/3FGVQIH

📢 Applications are now open!

We are now accepting applications for the Amgen Scholars Program at <a href="/UTSWGradSchool/">UTSW Graduate School of Biomedical Sciences</a>. Dive into cutting-edge research, attend skill-building sessions, and connect with our vibrant scientific community <a href="/ASP_GPO/">Amgen Scholars Global Program Office</a> 

Apply here ➡️ bit.ly/3FGVQIH
Dr. Arnaldo Díaz (@adiaz_phd) 's Twitter Profile Photo

I was very proud to reconnect with Juan L. Rivera-Correa at #2024NDiSTEM. I met Juan when he was an undergrad and now he is an Asst. Prof. at the New York City College of Technology. His research focused on understanding the role of autoimmunity during infections, such as malaria.

I was very proud to reconnect with <a href="/DrJRiveraCorrea/">Juan L. Rivera-Correa</a> at #2024NDiSTEM. I met Juan when he was an undergrad and now he is an Asst. Prof. at the New York City College of Technology. His research focused on understanding the role of autoimmunity during infections, such as malaria.
Juan L. Rivera-Correa (@drjriveracorrea) 's Twitter Profile Photo

Starting the year blessed: my first article as senior/last author and the first ever research article of the Rivera-Correa Lab. Details to come soon but for now, I just feel immensely proud and thankful. 🐶 🪱🇨🇷 🇵🇷 🥰 👨‍🔬 🔬 #latinxscientist #newPI #immunology #parasitology

Starting the year blessed: my first article as senior/last author and the first ever research article of the Rivera-Correa Lab. Details to come soon but for now, I just feel immensely proud and thankful. 🐶 🪱🇨🇷 🇵🇷 🥰 👨‍🔬 🔬  #latinxscientist #newPI #immunology #parasitology
Juan L. Rivera-Correa (@drjriveracorrea) 's Twitter Profile Photo

First article as senior/last author 🙏 👨‍🔬 🥹 and my new research adventures into veterinary infections and immunology 🐶 🪱 🇨🇷 #heartwormdisease #immunology #autoimmunity #parasitology #latinxscientist #publicationalert #newPI linkedin.com/posts/juan-l-r…

Nick Mark MD (@nickmmark) 's Twitter Profile Photo

🚨Apparently all NIH Study Sections have been suspended indefinitely. For those who don’t know, this means there won’t be any review of grants submitted to NIH Depending on how long this goes on for, this could lead to an interruption in billions in research funding.

Women In Malaria (@womeninmalaria) 's Twitter Profile Photo

📢The Preliminary Programme for the 2nd WiM Online Conference is out 🥳 🎉 The Early Bird Registration closes Feb 14 2025,  23.59 UTC (50 USD). Fee waivers are available for LMICs & you can also buy fee waivers or donate. Register and apply/donate: womeninmalaria.es/wim-conference/ 💙💛

📢The Preliminary Programme for the 2nd WiM Online Conference is out 🥳 🎉

The Early Bird Registration closes Feb 14 2025,  23.59 UTC (50 USD). Fee waivers are available for LMICs &amp; you can also buy fee waivers or donate. Register and apply/donate: womeninmalaria.es/wim-conference/ 💙💛
Juan L. Rivera-Correa (@drjriveracorrea) 's Twitter Profile Photo

Difficult times to be a scientist, but we owe it to ourselves to celebrate the small wins: After 6 years in the works, my first-author postdoctoral paper is finally out on JCI Insight #Bcells #Immunology #malaria insight.jci.org/articles/view/…

ASM (@asmicrobiology) 's Twitter Profile Photo

Measles—currently spreading in Texas & New Mexico—is more serious than a rash & fever: it also causes immune amnesia, leaving patients vulnerable to secondary infection. Vaccination prevents the spread of measles & reduces immune amnesia's impact. asm.social/2iE

JCI insight (@jci_insight) 's Twitter Profile Photo

.Juan L. Rivera-Correa & ASCI member Alessandra Pernis et al. find that ROCK1, a serine/threonine kinase, plays a critical role in protecting B cells when exposed to damaging and stressful environments. insight.jci.org/articles/view/…

.<a href="/DrJRiveraCorrea/">Juan L. Rivera-Correa</a> &amp; ASCI member Alessandra Pernis et al. find that ROCK1, a serine/threonine kinase, plays a critical role in protecting B cells when exposed to damaging and stressful environments. insight.jci.org/articles/view/…
Juan L. Rivera-Correa (@drjriveracorrea) 's Twitter Profile Photo

Check out our new editorial with my former ASM YA ambassadors Daniela Cejas 🇦🇷 and Fátima Rodríguez A. 🇵🇾! Thank you to the mBio ECB for the opportunity and support! 🇵🇷🇦🇷🇵🇾👨‍🔬👩‍🔬🦠🔬 #microbiology #earlycareerfaculty

Juan L. Rivera-Correa (@drjriveracorrea) 's Twitter Profile Photo

Check out latest article reporting anti-PS autoantibodies as pathological correlates during P. vivax malaria! 🙌🏽🇨🇴🙏🏽👨🏻‍🔬👩🏻‍🔬journals.plos.org/plosntds/artic…

Hispanic Outlook (@hispanicoutlook) 's Twitter Profile Photo

Happy #HSIsWeek to all the 615 #Hispanic-Serving institutions that are part of HACU! Hispanic Outlook congratulations all those who have reached #HSI status and to those emerging #HSIs that are striving to become a part of #HACU! 🎉🏫

Happy #HSIsWeek to all the 615 #Hispanic-Serving institutions that are part of <a href="/HACUNews/">HACU</a>! Hispanic Outlook congratulations all those who have reached #HSI status and to those emerging #HSIs that are striving to become a part of #HACU! 🎉🏫
Juan L. Rivera-Correa (@drjriveracorrea) 's Twitter Profile Photo

A new malaria drug cured 99% of cases in a late-stage study, a big step toward becoming the first new treatment of the disease in 25 years wsj.com/health/pharma/… via The Wall Street Journal